Item View & Download Statistics: A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial

From:   ever     To:   now     Change date range
Email Alert
RSS Feed
 
Geo Map
Save as a PNG Save as a JPEG
Region #
NA - North America 43
EU - Europe 12
AS - Asia, other 11
SA - South America 2
Unknown 3
Total 71
Save as a PNG Save as a JPEG
Country #
US - United States of America 43
SG - Singapore 9
IE - Ireland 4
RU - Russian Federation 3
ES - Spain 2
HK - Hong Kong 2
BR - Brazil 1
CL - Chile 1
FI - Finland 1
FR - France 1
other - Other Country 4
Total 71
Save as a PNG Save as a JPEG
City #
Ashburn 16
Singapore 5
Dublin 4
Hong Kong 2
Barcelona 1
Contagem 1
Council Bluffs 1
Des Moines 1
Helsinki 1
Moscow 1
other 38
Total 71
Save as a PNG Save as a JPEG


Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Tot
2021 21 1111 1100 00 9
2022 11 0160 1114 02 18
2023 10 0000 1100 11 5
2024 20 1111 7346 40 30
2025 53 1000 0000 00 9
Ever 71